Nuo Therapeutics, Inc. - AURX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | — | A | A | 7,516.0 | 1.5 | 11,274.0 | 0.0 | View | |
| Jan 26, 2026 | — | A | A | 35,000.0 | 1.5 | 52,500.0 | 0.0 | View | |
| Jan 26, 2026 | — | A | A | 1,750.0 | 1.5 | 2,625.0 | 0.0 | View | |
| Jan 26, 2026 | — | A | A | 26,667.0 | 1.5 | 40,000.5 | 0.0 | View | |
| Jan 26, 2026 | — | A | A | 1,333.0 | 1.5 | 1,999.5 | 0.0 | View | |
| Jan 26, 2026 | — | A | A | 2,050.0 | 1.5 | 3,075.0 | 0.0 | View | |
| Jan 05, 2026 | CEO/CFO | M | D | 125,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 05, 2026 | CEO/CFO | F | D | 25,381.0 | 1.97 | 50,000.57 | 2,046,374.0 | View | |
| Jan 05, 2026 | CEO/CFO | M | A | 125,000.0 | 0.4 | 50,000.0 | 2,071,755.0 | View | |
| Dec 22, 2025 | — | F | D | 13,750.0 | 2.0 | 27,500.0 | 172,654.0 | View | |
| Dec 22, 2025 | — | M | A | 68,750.0 | 0.4 | 27,500.0 | 186,404.0 | View | |
| Dec 11, 2025 | — | M | D | 50,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 11, 2025 | — | F | D | 9,091.0 | 2.2 | 20,000.2 | 108,294.0 | View | |
| Dec 11, 2025 | — | M | A | 50,000.0 | 0.4 | 20,000.0 | 117,385.0 | View | |
| Dec 11, 2025 | — | M | D | 50,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 11, 2025 | — | F | D | 9,091.0 | 2.2 | 20,000.2 | 108,294.0 | View | |
| Dec 11, 2025 | — | M | A | 50,000.0 | 0.4 | 20,000.0 | 117,385.0 | View | |
| Dec 03, 2025 | CEO/CFO | S | D | 200,000.0 | 1.5 | 300,000.0 | 1,946,755.0 | View |